Metraipolis › archive › dc_df65a9aeb73c

Unravelling Tinengotinib's Mechanistic Landscape in Triple-Negative Breast Cancer Via Network Pharmacology and in Silico Simulation Techniques — Europe PMC PMID:41100046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41100046
DOI
10.1007/s12013-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T06:40:31.629Z
SHA-256 of the archived text
c4184de884f131ea82d4ae463d78d3723217c31edfe96cb70a55362b6fa1f0f6
Stable URL of this page
https://metraipolis.com/documento/dc_df65a9aeb73c

How to cite

Unravelling Tinengotinib's Mechanistic Landscape in Triple-Negative Breast Cancer Via Network Pharmacology and in Silico Simulation Techniques — Europe PMC PMID:41100046 — Europe PMC (en), https://europepmc.org/article/MED/41100046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df65a9aeb73c (Metraipolis archive dc_df65a9aeb73c, sha256 c4184de884f131ea82d4ae463d78d3723217c31edfe96cb70a55362b6fa1f0f6)
BibTeX
@misc{dcdf65a9aeb73c,
  title = {Unravelling Tinengotinib's Mechanistic Landscape in Triple-Negative Breast Cancer Via Network Pharmacology and in Silico Simulation Techniques — Europe PMC PMID:41100046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41100046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df65a9aeb73c; sha256 c4184de884f131ea82d4ae463d78d3723217c31edfe96cb70a55362b6fa1f0f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41100046. Agents can read the archived copy with the MCP tool read_document.